Niacin stimulates adiponectin secretion through the GPR109A receptor

American Journal of Physiology - Endocrinology and Metabolism

Volumn 296, Issue 3, 2009, Pages

  Plaisance, Eric P ^a   Lukasova, Martina ^b   Offermanns, Stefan ^b   Zhang, Youyan ^c   Cao, Guoqing ^c   Judd, Robert L ^a  

^a AUBURN UNIVERSITY   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

HM74A; Lipolysis; Nicotinic acid; Nonesterified fatty acids; PUMA G

Indexed keywords

3 HYDROXYBUTYRIC ACID; ADIPONECTIN; CYCLIC AMP; FATTY ACID; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 109A; NICOTINIC ACID; PERTUSSIS TOXIN; PLACEBO; PROTEIN HM74A; PROTEIN PUMA G; UNCLASSIFIED DRUG; ADIPONECTIN, MOUSE; ANTILIPEMIC AGENT; GPR109A PROTEIN, HUMAN; GPR109B PROTEIN, MOUSE; NICOTINIC RECEPTOR;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN 3T3; CELL SURFACE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; LIPOLYSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RAT; SINGLE DRUG DOSE; ANIMAL; BLOOD; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SECRETION;

3-HYDROXYBUTYRIC ACID; 3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ANIMALS; ANTILIPEMIC AGENTS; CELLS, CULTURED; CYCLIC AMP; FATTY ACIDS, NONESTERIFIED; HUMANS; LIPOLYSIS; MICE; MICE, KNOCKOUT; NIACIN; PERTUSSIS TOXIN; RATS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NICOTINIC;

EID: 64749109569     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.91004.2008     Document Type: Article

References (38)

1. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79-83, 1999. (Pubitemid 29299050)
2. Bedi D, Clarke KJ, Dennis JC, Zhong Q, Brunson BL, Morrison EE, Judd RL. Endothelin-1 inhibits adiponectin secretion through a phosphatidylinositol 4,5-bisphosphate/actin-dependent mechanism. Biochem Biophys Res Commun 345: 332-339, 2006.
3. Bernstein EL, Koutkia P, Ljungquist K, Breu J, Canavan B, Grinspoon S. Acute regulation of adiponectin by free fatty acids. Metabolism 53: 790-793, 2004. (Pubitemid 38880913)
4. Carballo-Jane E, Gerckens LS, Luell S, Parlapiano AS, Wolff M, Colletti SL, Tata JR, Taggart AK, Waters MG, Richman JG, McCann ME, Forrest MJ. Comparison of rat and dog models of vasodilatation and lipolysis for the calculation of a therapeutic index for GPR109A agonists. J Pharmacol Toxicol Methods 56: 308-316, 2007. (Pubitemid 47539929)
5. Carlson LA. Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review. J Intern Med 258: 94-114, 2005.
6. Clark AB, Holt JM. Identifying and managing patients with hyperlipidemia. Am J Manag Care 3: 1211-1219, 1997.
7. 6a. Coronary Drug Project Research Group. Clofibrate and niacin in coronary heart disease. JAMA 231: 360-381, 1975.
8. Ganji S, Qin S, Zhang L, Kamanna V, Kashyap M. Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells. Atherosclerosis 202: 68-75, 2008.
9. Ganji S, Tavintharan S, Zhu D, Xing Y, Kamanna VS, Kashyap ML. Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells. J Lipid Res 45: 1835-1845, 2004. (Pubitemid 40990875)
10. Ge H, Li X, Weiszmann J, Wang P, Baribault H, Chen J, Tian H, Li Y. Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology 149: 4519-4526, 2008.
11. Halberg N, Henriksen M, Soderhamn N, Stallknecht B, Ploug T, Schjerling P, Dela F. Effect of intermittent fasting and refeeding on insulin action in healthy men. J Appl Physiol 99: 2128-2136, 2005. (Pubitemid 41691629)
12. Hoffstedt J, Arvidsson E, Sjölin E, Wåhlén K, Arner P. Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance. J Clin Endocrinol Metab 89: 1391-1396, 2004. (Pubitemid 38368442)
13. Jung JK, Johnson BR, Duong T, Decaire M, Uy J, Gharbaoui T, Boatman PD, Sage CR, Chen R, Richman JG, Connolly DT, Semple G. Analogues of acifran: agonists of the high and low affinity niacin receptors, GPR109a and GPR109b. J Med Chem 50: 1445-1448, 2007. (Pubitemid 46564367)
14. Kang L, Nagy LE. Chronic ethanol feeding suppresses beta-adrenergic receptor-stimulated lipolysis in adipocytes isolated from epididymal fat. Endocrinology 147: 4330-4338, 2006. (Pubitemid 44268384)
15. Kenakin T. Agonist-receptor efficacy. II. Agonist trafficking of receptor signals. Trends Pharmacol Sci 16: 232-238, 1995.
16. Knopp R. Evaluating niacin in its various forms. Am J Cardiol 86: 51L-56L, 2000.
17. Knopp R, Alagona P, Davidson M. Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia. Metabolism 47: 1097-1104, 1998. (Pubitemid 28428015)
18. Knopp R, Ginsberg J, Albers JJ. Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: clues to mechanism of action of niacin. Metabolism 34: 642-650, 1985. (Pubitemid 15036921)
19. Knopp RH. Clinical profiles of plain versus sustained-release niacin (Niaspan) and the physiologic rationale for nighttime dosing. Am J Cardiol 82: 24U-28U, 1998.
20. Kubota N, Yano W, Kubota T, Yamauchi T, Itoh S, Kumagai H, Kozono H, Takamoto I, Okamoto S, Shiuchi T, Suzuki R, Satoh H, Tsuchida A, Moroi M, Sugi K, Noda T, Ebinuma H, Ueta Y, Kondo T, Araki E, Ezaki O, Nagai R, Tobe K, Terauchi Y, Ueki K, Minokoshi Y, Kadowaki T. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab 6: 55-68, 2007. (Pubitemid 47007437)
21. Motoshima H, Wu X, Sinha MK, Hardy VE, Rosato EL, Barbot DJ, Rosato FE, Goldstein BJ. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab 87: 5662-5667, 2002. (Pubitemid 36034375)
22. Nguyen MT, Satoh H, Favelyukis S, Babendure JL, Imamura T, Sbodio JI, Zalevsky J, Dahiyat BI, Chi NW, Olefsky JM. JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J Biol Chem 280: 35361-35371, 2005. (Pubitemid 41532725)
23. Offermanns S. The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target. Trends Pharmacol Sci 27: 384-390, 2006. (Pubitemid 43963187)
24. Pérez-Matute P, Marti A, Martinez JA, Fernández-Otero MP, Stanhope KL, Havel PJ, Moreno-Aliaga MJ. Conjugated linoleic acid inhibits glucose metabolism, leptin and adiponectin secretion in primary cultured rat adipocytes. Mol Cell Endocrinol 268: 50-58, 2007.
25. Plaisance EP, Grandjean PW, Brunson BL, Judd RL. Increased total and high-molecular weight adiponectin after extended-release niacin. Metabolism 57: 404-409, 2008.
26. Richman JG. Nicotinic acid receptor agonists differentially activate downstream effectors. J Biol Chem 282: 18028-18036, 2007.
27. Soga T, Kamohara M, Takasaki J, Matsumoto S, Saito T, Ohishi T, Hiyama H, Matsuo A, Matsushime H, Furuichi K. Molecular identification of nicotinic acid receptor. Biochem Biophys Res Commun 303: 364-369, 2003. (Pubitemid 36338250)
28. Staiger H, Tschritter O, Kausch C, Lammers R, Stumvoll M, Häring HU. Human serum adiponectin levels are not under short-term negative control by free fatty acids in vivo. Horm Metab Res 34: 601-603, 2002. (Pubitemid 35390353)
29. Swarbrick M, Havel P. Physiological, pharmacological and nutritional regulation of circulating adiponectin concentrations in humans. Metab Syndr Relat Disord 6: 87-102, 2008.
30. Taggart AK, Kero J, Gan X, Cai TQ, Cheng K, Ippolito M, Ren N, Kaplan R, Wu K, Wu TJ, Jin L, Liaw C, Chen R, Richman J, Connolly D, Offermanns S, Wright SD, Waters MG. (D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J Biol Chem 280: 26649-26652, 2005. (Pubitemid 41040696)
31. Taylor AJ, Sullenberger LE, Lee HJ, Lee JK, Grace KA. Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation 110: 3512-3517, 2004.
32. Trujillo ME, Scherer PE. Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 257: 167-175, 2005.
33. Tunaru S, Kero J, Schaub A, Wufka C, Blaukat A, Pfeffer K, Offermanns S. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat Med 9: 352-355, 2003. (Pubitemid 36362793)
34. Wang W, Basinger A, Neese RA, Christiansen M, Hellerstein MK. Effects of nicotinic acid on fatty acid kinetics, fuel selection, and pathways of glucose production in women. Am J Physiol Endocrinol Metab 279: E50-E59, 2000. (Pubitemid 30609944)
35. Westphal S, Borucki K, Taneva E, Makarova R, Luley C. Adipokines and treatment with niacin. Metabolism 55: 1283-1285, 2006. (Pubitemid 44353552)
36. Westphal S, Borucki K, Taneva E, Makarova R, Luley C. Extended-release niacin raises adiponectin and leptin. Atherosclerosis 193: 361-365, 2007. (Pubitemid 47058098)
37. Wise A, Foord SM, Fraser NJ, Barnes AA, Elshourbagy N, Eilert M, Ignar DM, Murdock PR, Steplewski K, Green A, Brown AJ, Dowell SJ, Szekeres PG, Hassall DG, Marshall FH, Wilson S, Pike NB. Molecular identification of high and low affinity receptors for nicotinic acid. J Biol Chem 278: 9869-9874, 2003. (Pubitemid 36800490)
38. Zhang Y, Schmidt RJ, Foxworthy P, Emkey R, Oler JK, Large TH, Wang H, Su EW, Mosior MK, Eacho PI, Cao G. Niacin mediates lipolysis in adipose tissue through its G-protein coupled receptor HM74A. Biochem Biophys Res Commun 334: 729-732, 2005. (Pubitemid 40982427)